Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Genome-based Drug DiscoveryBiomarker

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1930612

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1930612

SNP Genotyping and Analysis Market

PUBLISHED:
PAGES: 342 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

Description

Table of Contents

List of Tables

SNP Genotyping and Analysis Market - Scope of Report

TMR's report on the global SNP Genotyping and Analysis Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global SNP Genotyping and Analysis Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global SNP Genotyping and Analysis Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Global SNP Genotyping and Analysis Market.

Market Snapshot
Market Value in 2024US$ 27.4 Bn
Market Value in 2035US$ 199.2 Bn
CAGR19.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Global SNP Genotyping and Analysis Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Global SNP Genotyping and Analysis Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the Global SNP Genotyping and Analysis Market .

The report delves into the competitive landscape of the Global SNP Genotyping and Analysis Market. Key players operating in the global SNP Genotyping and Analysis Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global SNP Genotyping and Analysis Market profiled in this report.

Key Questions Answered in Global SNP Genotyping and Analysis Market Report:

  • What is the sales/revenue generated by SNP Genotyping and Analysis Market across all regions during the forecast period?
  • What are the opportunities in the global SNP Genotyping and Analysis Market?
  • What are the major drivers, restraints, opportunities, and threats in the Market?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market?

Global SNP Genotyping and Analysis Market - Research Objectives and Research Approach

The comprehensive report on the global SNP Genotyping and Analysis Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global SNP Genotyping and Analysis Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market Share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the SNP Genotyping and Analysis Market.

Show more
Product Code: 432

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global SNP Genotyping and Analysis Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global SNP Genotyping and Analysis Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Recent Technological Advancements in SNP Genotyping and Analysis
  • 5.2. Key Industry Events
  • 5.3. Impact Analysis
  • 5.4. PESTEL Analysis
  • 5.5. PORTER's Five Forces Analysis
  • 5.6. Regulatory Scenario by Key Countries/Regions
  • 5.7. Healthcare Expenditure by Country
  • 5.8. Fund Raise/Investment Scenario
  • 5.9. Potential Investment Risks
  • 5.10. Ecosystem Analysis
  • 5.11. Go-to-Market Strategy for New Market Entrants

6. Global SNP Genotyping and Analysis Market Analysis and Forecast, by Sample Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Sample Type, 2020-2035
    • 6.3.1. Genomic DNA
    • 6.3.2. RNA
    • 6.3.3. Cell-free DNA (cfDNA)
    • 6.3.4. Plasma Samples
    • 6.3.5. Whole Blood
  • 6.4. Market Attractiveness Analysis, by Sample Type

7. Global SNP Genotyping and Analysis Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2020-2035
    • 7.3.1. Sanger Sequencing
    • 7.3.2. Next-Generation Sequencing (NGS)
    • 7.3.3. Microarray-Based Genotyping
    • 7.3.4. PCR-Based Genotyping
    • 7.3.5. Whole Genome Sequencing (WGS)
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global SNP Genotyping and Analysis Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2020-2035
    • 8.3.1. Disease Diagnostics
    • 8.3.2. Pharmacogenomics
    • 8.3.3. Precision Medicine
    • 8.3.4. Forensic Science
    • 8.3.5. Agriculture and Livestock
  • 8.4. Market Attractiveness Analysis, by Application

9. Global SNP Genotyping and Analysis Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2035
    • 9.3.1. Hospitals and Clinics
    • 9.3.2. Research Laboratories
    • 9.3.3. Pharmaceutical and Biotechnological Companies
    • 9.3.4. Diagnostic Laboratories
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global SNP Genotyping and Analysis Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America SNP Genotyping and Analysis Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Sample Type, 2020-2035
    • 11.2.1. Genomic DNA
    • 11.2.2. RNA
    • 11.2.3. Cell-free DNA (cfDNA)
    • 11.2.4. Plasma Samples
    • 11.2.5. Whole Blood
  • 11.3. Market Value Forecast, by Technology, 2020-2035
    • 11.3.1. Sanger Sequencing
    • 11.3.2. Next-Generation Sequencing (NGS)
    • 11.3.3. Microarray-Based Genotyping
    • 11.3.4. PCR-Based Genotyping
    • 11.3.5. Whole Genome Sequencing (WGS)
  • 11.4. Market Value Forecast, by Application, 2020-2035
    • 11.4.1. Disease Diagnostics
    • 11.4.2. Pharmacogenomics
    • 11.4.3. Precision Medicine
    • 11.4.4. Forensic Science
    • 11.4.5. Agriculture and Livestock
  • 11.5. Market Value Forecast, by End-user, 2020-2035
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Research Laboratories
    • 11.5.3. Pharmaceutical and Biotechnological Companies
    • 11.5.4. Diagnostic Laboratories
    • 11.5.5. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Sample Type
    • 11.7.2. By Technology
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe SNP Genotyping and Analysis Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Sample Type, 2020-2035
    • 12.2.1. Genomic DNA
    • 12.2.2. RNA
    • 12.2.3. Cell-free DNA (cfDNA)
    • 12.2.4. Plasma Samples
    • 12.2.5. Whole Blood
  • 12.3. Market Value Forecast, by Technology, 2020-2035
    • 12.3.1. Sanger Sequencing
    • 12.3.2. Next-Generation Sequencing (NGS)
    • 12.3.3. Microarray-Based Genotyping
    • 12.3.4. PCR-Based Genotyping
    • 12.3.5. Whole Genome Sequencing (WGS)
  • 12.4. Market Value Forecast, by Application, 2020-2035
    • 12.4.1. Disease Diagnostics
    • 12.4.2. Pharmacogenomics
    • 12.4.3. Precision Medicine
    • 12.4.4. Forensic Science
    • 12.4.5. Agriculture and Livestock
  • 12.5. Market Value Forecast, by End-user, 2020-2035
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Research Laboratories
    • 12.5.3. Pharmaceutical and Biotechnological Companies
    • 12.5.4. Diagnostic Laboratories
    • 12.5.5. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. The Netherlands
    • 12.6.7. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Sample Type
    • 12.7.2. By Technology
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific SNP Genotyping and Analysis Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Sample Type, 2020-2035
    • 13.2.1. Genomic DNA
    • 13.2.2. RNA
    • 13.2.3. Cell-free DNA (cfDNA)
    • 13.2.4. Plasma Samples
    • 13.2.5. Whole Blood
  • 13.3. Market Value Forecast, by Technology, 2020-2035
    • 13.3.1. Sanger Sequencing
    • 13.3.2. Next-Generation Sequencing (NGS)
    • 13.3.3. Microarray-Based Genotyping
    • 13.3.4. PCR-Based Genotyping
    • 13.3.5. Whole Genome Sequencing (WGS)
  • 13.4. Market Value Forecast, by Application, 2020-2035
    • 13.4.1. Disease Diagnostics
    • 13.4.2. Pharmacogenomics
    • 13.4.3. Precision Medicine
    • 13.4.4. Forensic Science
    • 13.4.5. Agriculture and Livestock
  • 13.5. Market Value Forecast, by End-user, 2020-2035
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Research Laboratories
    • 13.5.3. Pharmaceutical and Biotechnological Companies
    • 13.5.4. Diagnostic Laboratories
    • 13.5.5. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. South Korea
    • 13.6.5. ASEAN
    • 13.6.6. Australia & New Zealand
    • 13.6.7. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Sample Type
    • 13.7.2. By Technology
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America SNP Genotyping and Analysis Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Sample Type, 2020-2035
    • 14.2.1. Genomic DNA
    • 14.2.2. RNA
    • 14.2.3. Cell-free DNA (cfDNA)
    • 14.2.4. Plasma Samples
    • 14.2.5. Whole Blood
  • 14.3. Market Value Forecast, by Technology, 2020-2035
    • 14.3.1. Sanger Sequencing
    • 14.3.2. Next-Generation Sequencing (NGS)
    • 14.3.3. Microarray-Based Genotyping
    • 14.3.4. PCR-Based Genotyping
    • 14.3.5. Whole Genome Sequencing (WGS)
  • 14.4. Market Value Forecast, by Application, 2020-2035
    • 14.4.1. Disease Diagnostics
    • 14.4.2. Pharmacogenomics
    • 14.4.3. Precision Medicine
    • 14.4.4. Forensic Science
    • 14.4.5. Agriculture and Livestock
  • 14.5. Market Value Forecast, by End-user, 2020-2035
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Research Laboratories
    • 14.5.3. Pharmaceutical and Biotechnological Companies
    • 14.5.4. Diagnostic Laboratories
    • 14.5.5. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Argentina
    • 14.6.4. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Sample Type
    • 14.7.2. By Technology
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa SNP Genotyping and Analysis Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Sample Type, 2020-2015
    • 15.2.1. Genomic DNA
    • 15.2.2. RNA
    • 15.2.3. Cell-free DNA (cfDNA)
    • 15.2.4. Plasma Samples
    • 15.2.5. Whole Blood
  • 15.3. Market Value Forecast, by Technology, 2020-2015
    • 15.3.1. Sanger Sequencing
    • 15.3.2. Next-Generation Sequencing (NGS)
    • 15.3.3. Microarray-Based Genotyping
    • 15.3.4. PCR-Based Genotyping
    • 15.3.5. Whole Genome Sequencing (WGS)
  • 15.4. Market Value Forecast, by Application, 2020-2015
    • 15.4.1. Disease Diagnostics
    • 15.4.2. Pharmacogenomics
    • 15.4.3. Precision Medicine
    • 15.4.4. Forensic Science
    • 15.4.5. Agriculture and Livestock
  • 15.5. Market Value Forecast, by End-user, 2020-2015
    • 15.5.1. Hospitals and Clinics
    • 15.5.2. Research Laboratories
    • 15.5.3. Pharmaceutical and Biotechnological Companies
    • 15.5.4. Diagnostic Laboratories
    • 15.5.5. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020-2015
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Sample Type
    • 15.7.2. By Technology
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. Danaher Corporation
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. LGC
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Invitae
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Illumina
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. PerkinElmer
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. QIAGEN
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. BioRad Laboratories
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Agilent Technologies
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Thermo Fisher Scientific
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Roche Diagnostics
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Eurofins Scientific
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. Myriad Genetics
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Luminex Corporation
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments
    • 16.3.14. Other Prominent Players
      • 16.3.14.1. Company Overview
      • 16.3.14.2. Financial Overview
      • 16.3.14.3. Product Portfolio
      • 16.3.14.4. Business Strategies
      • 16.3.14.5. Recent Developments
Show more
Product Code: 432

List of Tables

  • Table 01: Global SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Sample Type, 2020 to 2035
  • Table 02: Global SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
  • Table 03: Global SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Application, 2020 to 2035
  • Table 04: Global SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
  • Table 05: Global SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Region, 2020 to 2035
  • Table 06: North America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Sample Type, 2020 to 2035
  • Table 07: North America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
  • Table 08: North America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Application, 2020 to 2035
  • Table 09: North America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
  • Table 10: North America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Region, 2020 to 2035
  • Table 11: Europe SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Sample Type, 2020 to 2035
  • Table 12: Europe SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
  • Table 13: Europe SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Application, 2020 to 2035
  • Table 14: Europe SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
  • Table 15: Europe SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Region, 2020 to 2035
  • Table 16: Asia Pacific SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Sample Type, 2020 to 2035
  • Table 17: Asia Pacific SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
  • Table 18: Asia Pacific SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Application, 2020 to 2035
  • Table 19: Asia Pacific SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
  • Table 20: Asia Pacific SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Region, 2020 to 2035
  • Table 21: Latin America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Sample Type, 2020 to 2035
  • Table 22: Latin America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
  • Table 23: Latin America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Application, 2020 to 2035
  • Table 24: Latin America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
  • Table 25: Latin America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Region, 2020 to 2035
  • Table 26: Middle East and Africa SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Sample Type, 2020 to 2035
  • Table 27: Middle East and Africa SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
  • Table 28: Middle East and Africa SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Application, 2020 to 2035
  • Table 29: Middle East and Africa SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
  • Table 30: Middle East and Africa SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, by Region, 2020 to 2035

List of Figures

  • Figure 01: Global SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 02: Global SNP Genotyping and Analysis Market Value Share Analysis, by Sample Type, 2024 and 2035
  • Figure 03: Global SNP Genotyping and Analysis Market Attractiveness Analysis, by Sample Type, 2025 to 2035
  • Figure 04: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Genomic DNA, 2020 to 2035
  • Figure 05: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by RNA, 2020 to 2035
  • Figure 06: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Cell-free DNA (cfDNA), 2020 to 2035
  • Figure 07: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Plasma Samples, 2020 to 2035
  • Figure 08: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Whole Blood, 2020 to 2035
  • Figure 09: Global SNP Genotyping and Analysis Market Value Share Analysis, by Technology, 2024 and 2035
  • Figure 10: Global SNP Genotyping and Analysis Market Attractiveness Analysis, by Technology, 2025 to 2035
  • Figure 11: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Sanger Sequencing, 2020 to 2035
  • Figure 12: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Next-Generation Sequencing (NGS), 2020 to 2035
  • Figure 13: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Microarray-Based Genotyping, 2020 to 2035
  • Figure 14: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by PCR-Based Genotyping, 2020 to 2035
  • Figure 15: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Whole Genome Sequencing (WGS), 2020 to 2035
  • Figure 16: Global SNP Genotyping and Analysis Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 17: Global SNP Genotyping and Analysis Market Attractiveness Analysis, by Application, 2025 to 2035
  • Figure 18: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Disease Diagnostics, 2020 to 2035
  • Figure 19: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Pharmacogenomics, 2020 to 2035
  • Figure 20: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Precision Medicine, 2020 to 2035
  • Figure 21: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Forensic Science, 2020 to 2035
  • Figure 22: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Agriculture and Livestock, 2020 to 2035
  • Figure 23: Global SNP Genotyping and Analysis Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 24: Global SNP Genotyping and Analysis Market Attractiveness Analysis, by End-user, 2025 to 2035
  • Figure 25: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Hospitals and Clinics, 2020 to 2035
  • Figure 26: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Research Laboratories, 2020 to 2035
  • Figure 27: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Pharmaceutical and Biotechnological Companies, 2020 to 2035
  • Figure 28: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Diagnostic Laboratories, 2020 to 2035
  • Figure 29: Global SNP Genotyping and Analysis Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 30: Global SNP Genotyping and Analysis Market Value Share Analysis, by Region, 2024 and 2035
  • Figure 31: Global SNP Genotyping and Analysis Market Attractiveness Analysis, by Region, 2025 to 2035
  • Figure 32: North America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 33: North America SNP Genotyping and Analysis Market Value Share Analysis, by Sample Type, 2024 and 2035
  • Figure 34: North America SNP Genotyping and Analysis Market Attractiveness Analysis, by Sample Type, 2025 to 2035
  • Figure 35: North America SNP Genotyping and Analysis Market Value Share Analysis, by Technology, 2024 and 2035
  • Figure 36: North America SNP Genotyping and Analysis Market Attractiveness Analysis, by Technology, 2025 to 2035
  • Figure 37: North America SNP Genotyping and Analysis Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 38: North America SNP Genotyping and Analysis Market Attractiveness Analysis, by Application, 2025 to 2035
  • Figure 39: North America SNP Genotyping and Analysis Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 40: North America SNP Genotyping and Analysis Market Attractiveness Analysis, by End-user, 2025 to 2035
  • Figure 41: North America SNP Genotyping and Analysis Market Value Share Analysis, by Region, 2024 and 2035
  • Figure 42: North America SNP Genotyping and Analysis Market Attractiveness Analysis, by Region, 2025 to 2035
  • Figure 43: Europe SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 44: Europe SNP Genotyping and Analysis Market Value Share Analysis, by Sample Type, 2024 and 2035
  • Figure 45: Europe SNP Genotyping and Analysis Market Attractiveness Analysis, by Sample Type, 2025 to 2035
  • Figure 46: Europe SNP Genotyping and Analysis Market Value Share Analysis, by Technology, 2024 and 2035
  • Figure 47: Europe SNP Genotyping and Analysis Market Attractiveness Analysis, by Technology, 2025 to 2035
  • Figure 48: Europe SNP Genotyping and Analysis Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 49: Europe SNP Genotyping and Analysis Market Attractiveness Analysis, by Application, 2025 to 2035
  • Figure 50: Europe SNP Genotyping and Analysis Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 51: Europe SNP Genotyping and Analysis Market Attractiveness Analysis, by End-user, 2025 to 2035
  • Figure 52: Europe SNP Genotyping and Analysis Market Value Share Analysis, by Region, 2024 and 2035
  • Figure 53: Europe SNP Genotyping and Analysis Market Attractiveness Analysis, by Region, 2025 to 2035
  • Figure 54: Asia Pacific SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 55: Asia Pacific SNP Genotyping and Analysis Market Value Share Analysis, by Sample Type, 2024 and 2035
  • Figure 56: Asia Pacific SNP Genotyping and Analysis Market Attractiveness Analysis, by Sample Type, 2025 to 2035
  • Figure 57: Asia Pacific SNP Genotyping and Analysis Market Value Share Analysis, by Technology, 2024 and 2035
  • Figure 58: Asia Pacific SNP Genotyping and Analysis Market Attractiveness Analysis, by Technology, 2025 to 2035
  • Figure 59: Asia Pacific SNP Genotyping and Analysis Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 60: Asia Pacific SNP Genotyping and Analysis Market Attractiveness Analysis, by Application, 2025 to 2035
  • Figure 61: Asia Pacific SNP Genotyping and Analysis Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 62: Asia Pacific SNP Genotyping and Analysis Market Attractiveness Analysis, by End-user, 2025 to 2035
  • Figure 63: Asia Pacific SNP Genotyping and Analysis Market Value Share Analysis, by Region, 2024 and 2035
  • Figure 64: Asia Pacific SNP Genotyping and Analysis Market Attractiveness Analysis, by Region, 2025 to 2035
  • Figure 65: Latin America SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 66: Latin America SNP Genotyping and Analysis Market Value Share Analysis, by Sample Type, 2024 and 2035
  • Figure 67: Latin America SNP Genotyping and Analysis Market Attractiveness Analysis, by Sample Type, 2025 to 2035
  • Figure 68: Latin America SNP Genotyping and Analysis Market Value Share Analysis, by Technology, 2024 and 2035
  • Figure 69: Latin America SNP Genotyping and Analysis Market Attractiveness Analysis, by Technology, 2025 to 2035
  • Figure 70: Latin America SNP Genotyping and Analysis Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 71: Latin America SNP Genotyping and Analysis Market Attractiveness Analysis, by Application, 2025 to 2035
  • Figure 72: Latin America SNP Genotyping and Analysis Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 73: Latin America SNP Genotyping and Analysis Market Attractiveness Analysis, by End-user, 2025 to 2035
  • Figure 74: Latin America SNP Genotyping and Analysis Market Value Share Analysis, by Region, 2024 and 2035
  • Figure 75: Latin America SNP Genotyping and Analysis Market Attractiveness Analysis, by Region, 2025 to 2035
  • Figure 76: Middle East and Africa SNP Genotyping and Analysis Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 77: Middle East and Africa SNP Genotyping and Analysis Market Value Share Analysis, by Sample Type, 2024 and 2035
  • Figure 78: Middle East and Africa SNP Genotyping and Analysis Market Attractiveness Analysis, by Sample Type, 2025 to 2035
  • Figure 79: Middle East and Africa SNP Genotyping and Analysis Market Value Share Analysis, by Technology, 2024 and 2035
  • Figure 80: Middle East and Africa SNP Genotyping and Analysis Market Attractiveness Analysis, by Technology, 2025 to 2035
  • Figure 81: Middle East and Africa SNP Genotyping and Analysis Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 82: Middle East and Africa SNP Genotyping and Analysis Market Attractiveness Analysis, by Application, 2025 to 2035
  • Figure 83: Middle East and Africa SNP Genotyping and Analysis Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 84: Middle East and Africa SNP Genotyping and Analysis Market Attractiveness Analysis, by End-user, 2025 to 2035
  • Figure 85: Middle East and Africa SNP Genotyping and Analysis Market Value Share Analysis, by Region, 2024 and 2035
  • Figure 86: Middle East and Africa SNP Genotyping and Analysis Market Attractiveness Analysis, by Region, 2025 to 2035
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!